HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Business (Health)

Set Alert for Business {Health}

Deals

Set Alert for Deals {Health}

Latest From Health & Deals

EU Business Round-Up: Probi Signs Oriflame Deal, Holland & Barrett Heads To China, Enzymatica Launches On Amazon

The latest European health & wellness business news: Probi partners with Swedish beauty firm Oriflame for probiotic launch; retailer Holland & Barrett enters the Chinese market with Alibaba's Tmall; and Enzymatica sees ColdZyme growth potential on Amazon.

Europe Health

Colgate Prioritizes Growing Brands Over Adding More; Increasing Costs Drive Prices Higher

Colgate is “not in a hurry” to make deals with valuations high for businesses it would target, says CEO Noel Wallace. Increasing commodity costs and rising inflation have the company prioritizing growth on existing businesses.

Business Strategies Sales & Earnings

Church & Dwight: Pregnancy Test Sales Show Consumer Confidence Strong Despite Pandemic

First Response pregnancy test sales didn’t decline during the pandemic as the underlying strength of the economy doesn’t slow consumer interest in expanding their families, says Church & Dwight CEO Matthew Farrell.

Business Strategies Commercial
See All

Strategy

Set Alert for Business Strategy {Health}

Latest From Health & Business Strategies

‘Heretical’ Rule Changes Could Make More Drugs Available OTC In US – Former NDAC Chair Brass

Harbor-UCLA Center for Clinical Pharmacology director Eric Brass says FDA should change DFL requirements, considering container labels as part of OTC labeling and reconsidering what information should be included on labels and threshold for consumer comprehension of labels.

Drug Approval Standards FDA

OTC Allergy Switch Approved For Bayer In US

CDER approves Bayer Healthcare’s azelastine 0.15% nasal antihistamine indicated for seasonal and perennial allergic rhinitis in adults and children 6 and older. Bayer says Astepro Allergy is first steroid-free antihistamine for allergies available OTC in the US and the first indicated for indoor and outdoor allergy relief.

Prescription To Otc Switch FDA

People On The Move: Appointments At Stada, CHPA, Valbiotis And DSA

The latest global health and wellness industry appointments: Stada hires Uriach's Roura to lead Spanish OTC business; CHPA elects J&J's Goodridge; Valbiotis brings in Ipsen's Bessy; and Mannatech's Bala joins DSA's board.

Appointments Leadership
See All

Sales & Earnings

Set Alert for Sales & Earnings {Health}

Latest From Health & Sales & Earnings

Colgate Prioritizes Growing Brands Over Adding More; Increasing Costs Drive Prices Higher

Colgate is “not in a hurry” to make deals with valuations high for businesses it would target, says CEO Noel Wallace. Increasing commodity costs and rising inflation have the company prioritizing growth on existing businesses.

Business Strategies Sales & Earnings

Church & Dwight: Pregnancy Test Sales Show Consumer Confidence Strong Despite Pandemic

First Response pregnancy test sales didn’t decline during the pandemic as the underlying strength of the economy doesn’t slow consumer interest in expanding their families, says Church & Dwight CEO Matthew Farrell.

Business Strategies Commercial

Deal For TheraTears Emphasizes Prestige Is A Consumer Health Business, Akorn Isn't

Both firms announce agreement for Prestige to pay Akorn $230m cash for TheraTear, Diabetic Tussin and Zostrix OTCs and MagOx and Multi-betic supplements. Akorn says the agreement is "to sell its Consumer Health business,” even though it retains two consumer brands.

OTC Drugs Dietary Supplements
See All

Litigation

Set Alert for Legal Issues {Health}

Latest From Health & Legal Issues

FTC Chair’s Anti-Trust Focus Could Impact Pricing, Sales Across Consumer Packaged Goods Sectors

Health, beauty and wellness industry stakeholders believe Lina Khan’s appointment increases chances FTC will aggressively enforce against e-commerce giant Amazon. Agency movement alleging antitrust against Amazon could impact the pricing and sales of products online.

E-Commerce Enforcement

USPTO Cannabinoid Trademarks Approach Aligns With FDA Ingredient Regulation: Divert From Norm

Cannabinoid products have been available in US since at least 2012, when states began legalizing cannabis, but the earliest USPTO is recognizing submissions for those marks is December 2018 and it won’t register trademarks until FDA allows lawful use of the ingredients in non-drug products.

Cannabidiol CBD Regulation

US Courts Reject Reinstating FDA's Homeopathic Drug Policy As Challenge To Change Proceeds

Decisions in US Circuit and District courts for District of Columba are on complaint by Rx drug firm MediNatura, but should resonate for OTC homeopathic firms as well as all businesses across the sector. MediNatura appealed district ruling rejecting request for injunction against FDA’s withdrawal of 1988 homeopathic CPG.

FDA Legal Issues
See All
UsernamePublicRestriction

Register